Cardinal Health Inc. recalls Wegovy (semaglutide) injection
- Published
- 7 May 2025
- Units affected
- 48 Cartons
- Agency
- FDA
- Country
- United States
The hazard
Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.
- Brand / company
- Cardinal Health Inc.
- Codes / lots
- Lot PZFDE06, Exp 08/31/2025
- Distribution
- NC, SC, VA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 7 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.